Followers | 22 |
Posts | 4027 |
Boards Moderated | 1 |
Alias Born | 08/18/2017 |
Wednesday, December 01, 2021 10:31:36 AM
Canada NewsWire
VANCOUVER, BC, Dec. 1, 2021
THC - CSE
THCBF - OTC
TFHD .F
VANCOUVER, BC, Dec. 1, 2021 /CNW/ - THC BioMed Intl Ltd. (CSE: THC) ("THC BioMed" or the "Company") is pleased to report its financial results for the three months ended October 31, 2021.
THC BioMed Intl Ltd. Logo (CNW Group/THC BioMed)
Q1 HIGHLIGHTS
Produced a gross margin profit after fair value adjustments of $711,761 and net income of $25,006
Sales revenue increased 83% period to period
Sales of edibles in Q1 made up 21.3% of total sales
Facility buildout completed
Received a Notice of Allowance from the Canadian Patent and Trademark Office regarding its patent application for the invention of a Contrast Illuminated Tamper Resistant Plant Shipping Container, or the Clone Shipper unit. The Notice of Application is not a grant of patent rights at this time but a notice from the Examiner that the Application is being allowed.
https://www.otcmarkets.com/stock/THCBF/news/THC-BioMed-Releases-First-Quarter-Results?id=333510
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM